We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pfizer's Celebrex Receives Black-Box Warning Label, New Indication
Pfizer's Celebrex Receives Black-Box Warning Label, New Indication
August 5, 2005
The FDA has approved a new black-box warning for Pfizer’s arthritis pain drug Celebrex that highlights the increased risk of cardiovascular (CV) events associated with the product.